Skip to main content
TipRanks
Go Ultimate75% OFF

Surgical Science Sweden AB (SUS) Ratios

5 Followers

Surgical Science Sweden AB Ratios

SE:SUS's free cash flow for Q3 2026 was kr27.62M. For the 2026 fiscal year, SE:SUS's free cash flow was decreased by kr-14.90M and operating cash flow was kr42.52M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio4.072.784.222.702.65
Quick Ratio3.362.433.562.262.17
Cash Ratio2.121.892.701.421.36
Solvency Ratio0.360.300.810.560.29
Operating Cash Flow Ratio0.270.271.010.420.17
Short-Term Operating Cash Flow Coverage3.557.360.000.000.00
Net Current Asset Valuekr 766.37Mkr 774.97Mkr 633.73Mkr 413.26Mkr 223.85M
Leverage Ratios
Debt-to-Assets Ratio0.020.050.010.000.00
Debt-to-Equity Ratio0.020.060.010.000.00
Debt-to-Capital Ratio0.020.060.010.000.00
Long-Term Debt-to-Capital Ratio0.000.050.000.000.00
Financial Leverage Ratio1.101.131.081.101.11
Debt Service Coverage Ratio5.538.13442.44192.415.90
Interest Coverage Ratio17.3425.41288.34124.553.87
Debt to Market Cap0.010.030.000.000.00
Interest Debt Per Share1.675.840.800.310.82
Net Debt to EBITDA-2.79-3.01-1.83-1.54-2.65
Profitability Margins
Gross Profit Margin58.14%67.63%69.42%66.23%72.51%
EBIT Margin10.98%18.52%30.46%28.37%24.20%
EBITDA Margin19.38%25.37%36.76%33.80%31.37%
Operating Profit Margin10.98%16.32%21.43%20.25%24.20%
Pretax Profit Margin10.09%17.88%30.39%25.94%17.94%
Net Profit Margin6.73%14.89%26.50%23.42%23.52%
Continuous Operations Profit Margin6.73%14.89%26.50%23.42%23.52%
Net Income Per EBT66.73%83.27%87.22%90.30%131.07%
EBT Per EBIT91.89%109.54%141.82%128.08%74.14%
Return on Assets (ROA)1.42%2.40%4.98%4.04%2.17%
Return on Equity (ROE)1.56%2.73%5.38%4.44%2.41%
Return on Capital Employed (ROCE)2.48%2.91%4.23%3.74%2.37%
Return on Invested Capital (ROIC)1.64%2.41%3.69%3.38%2.37%
Return on Tangible Assets5.17%8.48%21.52%20.79%12.59%
Earnings Yield4.03%1.65%2.52%2.25%0.72%
Efficiency Ratios
Receivables Turnover3.433.427.983.292.04
Payables Turnover11.464.906.544.132.93
Inventory Turnover2.021.591.752.010.89
Fixed Asset Turnover9.338.7111.5215.639.55
Asset Turnover0.210.160.190.170.09
Working Capital Turnover Ratio1.101.061.381.771.51
Cash Conversion Cycle255.50261.07198.72204.21463.93
Days of Sales Outstanding106.38106.5845.73111.03178.92
Days of Inventory Outstanding180.97229.04208.81181.65409.42
Days of Payables Outstanding31.8574.5455.8288.47124.40
Operating Cycle287.35335.61254.54292.68588.34
Cash Flow Ratios
Operating Cash Flow Per Share1.562.694.682.550.92
Free Cash Flow Per Share1.331.763.811.870.58
Dividend Paid and CapEx Coverage Ratio6.832.895.403.752.72
Capital Expenditure Coverage Ratio6.832.895.403.752.72
Operating Cash Flow Coverage Ratio1.010.475.958.823.24
Operating Cash Flow to Sales Ratio0.080.160.270.160.11
Free Cash Flow Yield4.11%1.13%2.09%1.13%0.21%
Valuation Ratios
Price-to-Earnings (P/E) Ratio24.8160.4339.7344.51138.68
Price-to-Sales (P/S) Ratio1.679.0010.5310.4332.61
Price-to-Book (P/B) Ratio0.391.652.141.973.34
Price-to-Free Cash Flow (P/FCF) Ratio24.3588.6947.8788.13484.11
Price-to-Operating Cash Flow Ratio20.7857.9739.0164.62306.03
Price-to-Earnings Growth (PEG) Ratio-0.50-1.381.650.540.39
Enterprise Value Multiple5.8332.4526.8129.30101.31
Enterprise Value1.12B7.28B8.70B7.95B11.66B
EV to EBITDA5.8332.4526.8129.30101.31
EV to Sales1.138.239.859.9031.78
EV to Free Cash Flow16.4581.1544.8183.72471.78
EV to Operating Cash Flow14.0553.0536.5161.38298.23
Tangible Book Value Per Share17.1117.6614.339.676.87
Shareholders’ Equity Per Share83.7494.6385.3283.3984.38
Tax and Other Ratios
Effective Tax Rate0.330.170.130.10-0.31
Revenue Per Share19.4517.3317.3315.808.63
Net Income Per Share1.312.584.593.702.03
Tax Burden0.670.830.870.901.31
Interest Burden0.920.971.000.910.74
Research & Development to Revenue0.190.220.210.220.18
SG&A to Revenue0.280.290.080.080.18
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality1.191.041.020.800.69

Currency in SEK